Intervenções clínicas aos efeitos adversos dos antivenenos: Revisão de escopo
| dc.contributor.advisor | Sachett, Jacqueline de Almeida Gonçalves | |
| dc.contributor.advisor-lattes | http://lattes.cnpq.br/0998695766654411 | |
| dc.contributor.author | Barbosa, Marden de Castro | |
| dc.contributor.author-lattes | http://lattes.cnpq.br/6354232441392097 | |
| dc.contributor.referee1 | Sachett, Jacqueline de Almeida Gonçalves | |
| dc.contributor.referee1Lattes | http://lattes.cnpq.br/0998695766654411 | |
| dc.contributor.referee2 | Farias, Altair Seabra de | |
| dc.contributor.referee2Lattes | http://lattes.cnpq.br/3546793843441229 | |
| dc.contributor.referee3 | Osis, Sibila Lilian | |
| dc.contributor.referee3Lattes | http://lattes.cnpq.br/3002652539563151 | |
| dc.date.accessioned | 2025-01-06T19:41:39Z | |
| dc.date.issued | 2024-12-13 | |
| dc.description.abstract | Mapping clinical interventions to the adverse effects of antivenoms, as well as the characteristics of these antivenoms that favor the occurrence of such events. Method: Scoping review. Articles in English and Portuguese were included, with no time limit, that answered the following research question: What clinical interventions have been used in the prevention and control of adverse effects to antivenoms and what are the characteristics of these antivenoms that have favored these events? Database selection: Embase (Elsevier), Web of Science (Clarivate), Scopus (Elsevier), and Cochrane Library. Duplicated articles, studies involving animals, and studies incompatible with the proposed research question were excluded. Results: Of the 210 articles identified, 11 were selected. The main strategies for preventing adverse events of antivenoms consist of the administration of antihistamines, corticosteroids, and adrenaline. The efficacy of antihistamines as well as hydrocortisone used alone did not demonstrate effectiveness in preventing the incidence of adverse effects after the administration of antivenoms, even 2 to 4 hours before therapy. In the context of serum sickness, corticosteroids are presented as the indicated therapy. Adrenaline remains the drug of choice in the management of adverse effects, especially anaphylactic shock. Antivenoms with whole immunoglobulin, larger amounts of heterologous proteins, and administration of high doses confer a higher risk of adverse events. Conclusion: The use of antihistamines and corticosteroids alone is not effective in preventing side effects caused by antivenoms. However, adrenaline remains the alternative when anaphylactic shock is an outcome. However, careful evaluation is necessary in the prolonged use of this drug when there is recurrence of anaphylaxis and this has a biphasic course. Antivenoms that have a low degree of purification of heterologous proteins and immunoglobulins require the administration of larger quantities and, therefore, expose the victim to a high risk of adverse reactions. | |
| dc.description.resumo | Mapear as intervenções clínicas aos efeitos adversos dos antivenenos bem como as características destes que favorecem a ocorrência de tais eventos. Método: Revisão de escopo. Foram incluídos artigos em inglês, português, sem recorte temporal, que respondessem à seguinte pergunta de pesquisa: Que intervenções clínicas têm sido utilizadas na prevenção e controle dos efeitos adversos aos antivenenos e quais as características destes têm favorecido esses eventos? Seleção nas bases de dados: Embase (Elsevier), Web of Science (Clarivate), Scopus (Elsevier) e Cochrane Library. Não foram incluídos, artigos duplicados, estudos envolvendo animais, e estudos não compatíveis com a questão de pesquisa proposta. Resultados: Dos 210 artigos identificados, foram selecionados 11. As principais estratégias de prevenção dos eventos adversos do antivenenos consistem na administração de anti- histamínicos, corticosteroides e adrenalina. A eficácia dos anti-histamínicos bem como da hidrocortisona usados de forma isolada não demonstrou efetividade em evitar a incidência de efeitos adversos após a administração dos antivenenos mesmo 2 a 4 horas antes da terapia. No contexto da doença do soro, os corticosteroides são apresentados como terapia indicada. A adrenalina continua sendo o fármaco de escolha no controle dos efeitos adversos, especialmente do choque anafilático. Antivenenos com imunoglobulina inteira, maiores quantidades de proteínas heterólogas e administração de altas doses conferem maior risco de eventos adversos. Conclusão: O uso de anti-histamínicos e corticosteroides de forma isolada não é eficaz na prevenção de efeitos colaterais causados pelos antivenenos. Contudo, a adrenalina continua sendo a alternativa quando o choque anafilático é um desfecho. Porém, é necessária avaliação criteriosa no uso prolongado desse medicamento quando há recidiva da anafilaxia e essa tem 6 um curso bifásico. Os antivenenos que tem baixo grau de purificação de proteínas heterólogas e imunoglobulinas, demandam administração de maiores quantidades e, portanto, expõem o acidentado a um risco elevado de reações adversas. | |
| dc.identifier.citation | BARBOSA, Marden de Castro. Intervenções clínicas aos efeitos adversos dos antivenenos: Revisão de escopo. Trabalho de Conclusão de Curso (Bacharelado em Enfermagem). UEA, Manaus, 2024 | |
| dc.identifier.uri | https://ri.uea.edu.br/handle/riuea/7191 | |
| dc.publisher | Universidade do Estado do Amazonas | |
| dc.publisher.initials | UEA | |
| dc.relation.references | 1. Brasil M da S. Acidente por animais peçonhentos - Notificações registradas no Sistema de Informação de Agravos de Notificação. 2023. 2. Brasil M da S. Acidentes por animais peçonhentos. In: SVSA/MS, editor. Guia de Vigilância em Saúde. 6th ed. Brasilia; 2023. p. 1123–47. 3. Brasil FN de S. Manual de diagnóstico e tratamento de acidentes por animais peçonhentos. 2nd ed. Acessoria de Comunicação e Educação em Saúde, editor. Brasilia; 2001. 4. Abbas AK, Lichtman AH, Pillai S. Hipersensibilidade. In: Koogan G, editor. Imunologia Básica - Funções e Distúrbios do Sistema Imunológico. 6a . 2021. 5. Wen F. Soroterapia. In: Sarvier, editor. Animais peçonhentos no Brasil: Biologia, clínica e terapêutica dos acidentes. 2o . Indianópolis; 2009. p. 432–46. 6. Fan HW, Marcopito LF, Cardoso JLC, França FOS, Malaque CMS, Ferrari RA, et al. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. Br Med J [Internet]. 1999;318(7196):1451–3. Available from: 23 https://www.embase.com/search/results?subaction=viewrecord&id=L29243703&from =export 7. Isbister GK, Shahmy S, Mohamed F, Abeysinghe C, Karunathilake H, Ariaratnam A. A randomised controlled trial of two infusion rates to decrease reactions to antivenom. PLoS One [Internet]. 2012;7(6). Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L365024125&from =export 8. Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z. JBI Manual for Evidence Synthesis. 2024. p. 417–75. 9. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med [Internet]. 2018 Sep 4;169(7):467–73. Available from: https://doi.org/10.7326/M18-0850 10. Cardoso D, Yamaguchi I, Silva A. Produção de soros antitoxinas e perspectivas de modernização por técnicas de biologia molecular. In: Sarvier, editor. Animais peçonhentos no Brasil: Biologia, clínica e terapêutica dos acidentes. 2a . Indianóplis; 2009. p. 419–32. 11. Dart RC, Bush SP, Heard K, Arnold TC, Sutter M, Campagne D, et al. The Efficacy of Antivenin Latrodectus (Black Widow) Equine Immune F(ab)2 Versus Placebo in the Treatment of Latrodectism: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Ann Emerg Med [Internet]. 2019;74(3):439–49. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L2001732495&fro m=export 12. Boyer L V, Theodorou AA, Berg RA, Mallie J, Chávez-Méndez A, García-Ubbelohde W, et al. Antivenom for critically ill children with neurotoxicity from scorpion stings. New England Journal of Medicine [Internet]. 2009;360(20):2090–8. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L354663244&from =export 13. Bush SP, Ruha AM, Seifert SA, Morgan DL, Lewis BJ, Arnold TC, et al. A prospective, multicenter, double-blind, randomized, controlled, clinical trial comparing Crotalinae Equine Immune F(ab’)2 and Crotalidae Polyvalent Immune Fab (ovine) for the treatment of US Crotalinae envenomation. Clin Toxicol [Internet]. 2014;52(7):686–7. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L71567060&from =export 14. Hung HT, Höjer J, Kiem TX, Du NT. A Controlled Clinical Trial of A Novel Antivenom in Patients Envenomed by Bungarus multicinctus. Journal of Medical Toxicology [Internet]. 2010;6(4):393–7. Available from: 24 https://www.embase.com/search/results?subaction=viewrecord&id=L50857552&from =export 15. Lamb T, Stewart D, Warrell DA, Lalloo DG, Jagpal P, Jones D, et al. Moderate-to-severe Vipera berus envenoming requiring ViperaTAb antivenom therapy in the UK. Clin Toxicol. 2021;59(11):992–1001. 16. Thomas L, Tyburn B, Lang J, Ketterlé J, Biao T, Moravie V, et al. Snake (Bothrops lanceolatus) F(ab’)2 antivenom (equine) use in Martinique: Safety and efficacy. Reanimation Urgences [Internet]. 1998;7(4):381–7. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L29159240&from =export 17. Sharma SK, Alirol E, Ghimire A, Shrestha S, Jha R, Parajuli SB, et al. Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom. J Trop Med. 2019;2019. 18. Jorge MT, Cardoso JLC, Castro SCB, Ribeiro L, Franca FOS, Sbrogio de Almeida ME, et al. A randomized “blinded” comparison of two doses of antivenom in the treatment of Bothrops envenoming in Sao Paulo, Brazil. Trans R Soc Trop Med Hyg [Internet]. 1995;89(1):111–4. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L25099062&from =export 19. Johnston CI, Ryan NM, Page CB, Buckley NA, Brown SGA, O’Leary MA, et al. The Australian snakebite project, 2005–2015 (ASP-20). Medical Journal of Australia. 2017;207(3):119–25. 20. Yeoh A, Kadir A, Varikara K. Antivenom usage in tiger snake envenomation as per Australian snakebite project (ASP) protocol: Case report based on rural experience. Intern Med J [Internet]. 2017;47:19–20. Available from: https://www.embase.com/search/results?subaction=viewrecord&id=L616279626&from =export 21. Morais V. Antivenom therapy: efficacy of premedication for the prevention of adverse reactions. Journal of Venomous Animals and Toxins including Tropical Diseases. 2018;24. 22. Habib AG. Effect of Pre-Medication on Early Adverse Reactions Following Antivenom Use in Snakebite A Systematic Review and Meta-Analysis. Drug Saf. 2011;34(10):869– 80. 23. Kularatne SAM, Weerakoon K, Silva A, Maduwage K, Walathara C, Rathnayake I, et al. Efficacy of intravenous hydrocortisone administered 2-4 h prior to antivenom as prophylaxis against adverse drug reactions to snake antivenom in Sri Lanka: An open labelled randomized controlled trial. TOXICON. 2016;120:159–65. | |
| dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Brazil | en |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/br/ | |
| dc.subject | Antivenenos | |
| dc.subject | Efeito adverso | |
| dc.subject | Hipersensibilidade | |
| dc.title | Intervenções clínicas aos efeitos adversos dos antivenenos: Revisão de escopo | |
| dc.title.alternative | Clinical interventions for adverse effects of antivenoms: Scoping review | |
| dc.type | Trabalho de Conclusão de Curso |
Arquivos
Pacote original
1 - 1 de 1
Carregando...
- Nome:
- Intervenções_clínicas_aos_efeitos.pdf
- Tamanho:
- 427.97 KB
- Formato:
- Adobe Portable Document Format
